The Brand Name FENOLIP Has Generic Salt :: Fenofibrate 

FENOLIP  Is From Company Cipla Priced :: Rs. 78

FENOLIP have Fenofibrate is comes under Sub class Anti Hyperlipidemics of  Main Class Cardiovascular System

Main Medicine Class:: Cardiovascular System  Sub Medicine Class :: Anti Hyperlipidemics 

 Salt Name :  OR Generic Name Form Price : MRP /Probable Packing
Fenofibrate  TAB  Rs. 78  10
Brand Name Company / Manufacturers Strength Unit Price / 10
 FENOLIP  Cipla  160MG  10 Rs. 78

Company  Brand Name  Salt Combination Main Medical Class Sub Medical Class
 From Cipla :: FENOLIP  Fenofibrate  Cardiovascular System Anti Hyperlipidemics

Indications for Drugs ::


Drug Dose ::

Adult: PO : Standard micronised formulation: Initially, 200 mg once daily. For non-micronised formulations: Initial: 200-300 mg/day in divided doses. Usual range: 200-400 mg/day. Formulation w/ improved bioavailability: 40-160 mg once daily may be used.

Contraindication ::

Hypersensitivity; severe hepatic and renal impairment. Unexplained persistent liver function abnormality and primary biliary cirrhosis; preexisting gall bladder disease. Pregnancy, lactation.

Drug Precautions ::

Renal or hepatic impairment. Monitor LFTs and blood counts regularly. Increased risk of cholelithiasis, pancreatitis, skeletal muscle effects. Withdraw treatment if no adequate response after 2 mth of treatment at max recommended dose.

Drug Side Effects ::

Headache, dizziness, asthaenia, fatigue, arrhythmia, photosensitivity, eczema, dizziness, vaginitis, paraesthesia, rhinitis, cough, sinusitis, allergic pulmonary alveolitis, polyuria, myopathy, myositis, arthralgia, myalgia, myasthenia. Potentially Fatal: Hepatitis, cholecystitis.

Pregnancy category ::
Pregnancy category


Drug Mode of Action ::  

Fenofibrate, a fibric acid derivative, lowers plasma triglyceride by activating lipoprotein lipase thus increasing catabolism of VLDL w/ consequent increase in HDL levels.

Drug Interactions ::

Decreased absorption w/ bile acid sequestrants (e.g. colestyramine). May increase risk of ciclosporin-induced nephrotoxicity. Increased risk of muscle toxicity w/ HMG-CoA reductase inhibitors (e.g. simvastatin). May increase risk of bleeding w/ oral anticoagulants.


Disclaimer ::

The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.
{{ reviewsOverall }} / 5 Users (0 votes)
What people say... Leave your rating
Order by:

Be the first to leave a review.

User Avatar User Avatar
{{{ review.rating_title }}}
{{{review.rating_comment | nl2br}}}

Show more
{{ pageNumber+1 }}
Leave your rating